Using combined iron supplements to reduce blood transfusions in heart surgery patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to determine if a combined regimen of intravenous sucrose iron, subcutaneous erythropoietin, and intravenous vitamin C can effectively reduce the need for blood transfusions in adults with iron-deficiency anemia undergoing major elective cardiac surgery. Participants will be randomly assigned to receive either the combined treatment or standard care before their surgery. The study will monitor the total volume of blood transfusions required during and after the surgery, as well as any potential side effects associated with the treatment. Follow-up assessments will occur at various time points up to 90 days post-surgery to evaluate recovery and transfusion needs.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Participants must be at least 18 years of age.
2. Major cardiac surgery should encompass procedures such as coronary artery bypass grafting (CABG), valve surgery, or a combination of both.
3. Iron deficiency anemia is defined as having a ferritin level below 100 μg/L or a ferritin level below 300 μg/L accompanied by a transferrin saturation below 25%. Additionally, hemoglobin levels should range between 90 and 130 g/L for men or between 90 and 120 g/L for women.
4. The American Society of Anesthesiologists (ASA) classification should fall within Grade 1-3.
5. Prior to participation, the patient or their legal representative must provide informed consent.

Exclusion Criteria:

1. Contraindications for the administration of iron sucrose, ascorbic acid, or rHuEPO.
2. Presence of a temperature exceeding 37.5 °C or the utilization of non-prophylactic antibiotics.
3. Individuals with a weight equal to or less than 50kg.
4. Individuals with a family history of haemochromatosis or thalassaemia, or those with a transferrin saturation level exceeding 50% or a documented history of iron overload.
5. Presence of other known haematological disorders such as folic acid or vitamin B12 deficiency, haemolytic anaemia, haemoglobinopathies, iron granulocytic anaemia, G6PD deficiency, etc.
6. Requirement for emergency surgical intervention.
7. Severe hepatic or renal impairment, ALT \>3 times the upper limit of normal value or AST \>3 times the upper limit of normal value, creatinine \>1.5 times the upper limit of normal value
8. Pregnant or lactating women
9. history of blood transfusion, intravenous iron or ascorbic acid use within 12 weeks prior to surgery
10. Acute blood loss, gastrointestinal bleeding, etc. in the preoperative period.

Where it's running

• Department of Anesthesiology, Second Affiliated Hospital, Zhejiang University School of Medicine
  Hangzhou, Zhejiang, China Recruiting

Study contacts

• Study coordinator: Qi Gao, Dr.
• Email: gaoqi19950203@163.com
• Phone: 19857136919

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Iron status at ICU discharge in adults with anemia after critical illness

  We are testing whether iron deficiency is common at ICU discharge and whether it relates to how well patients recover after leaving the ICU.

  Recruiting Università degli Studi di Ferrara · Brussels and 3 other locations · NCT07781540

• CTX001: a pill to help iron move where it’s needed in healthy adults

  This early test checks if CTX001 is safe and how it behaves in the body to help iron get into red blood cells in healthy adults, with or without iron and with or without food.

  Recruiting Early Phase 1 Cajal Therapeutics Inc. · Melbourne, Victoria · NCT07577817

• Sucrosomial iron for children with celiac disease and iron deficiency

  This trial tests whether adding oral Sucrosomial® (Sideral forte®) iron drops to a gluten-free diet helps children aged 8–18 with newly diagnosed celiac disease and low iron or anemia recover hemoglobin and iron stores faster than diet alone.

  Recruiting Istituto Giannina Gaslini · Genova, Italy · NCT07563582

• DISC-0974-201 for adults with IBD-related anemia

  This Phase 2 trial will test whether DISC-0974-201 helps adults with inflammatory bowel disease who have anemia driven by inflammation.

  Recruiting at 15 sites Phase 2 Disc Medicine, Inc · Birmingham, Alabama and 14 other locations · NCT07368972

• Improving ready-to-use therapeutic foods to help malnourished Kenyan children absorb iron

  This project will test whether changing the iron in ready-to-use therapeutic foods helps severely malnourished Kenyan children absorb iron better and recover from anemia.

  Recruiting ETH Zurich · Msambweni, Kwale County and 1 other locations · NCT07315295

• Preoperative IV ferric derisomaltose to prevent anemia and improve quality of life in obese patients having bariatric surgery

  This trial tests whether a single preoperative IV ferric derisomaltose dose, compared with saline placebo, prevents postoperative anemia and improves quality of life for iron-deficient obese patients undergoing bariatric surgery.

  Recruiting China-Japan Friendship Hospital · Beijing · NCT07236788

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.